Mobia Medical Announces Pricing of Initial Public Offering
Mobia Medical
May 8, 2026
Baird Capital has completed the acquisition of Blue Matter Consulting, a healthcare services other business in the United States, for $450m. Blue Matter Consulting supports life sciences customers with consulting services that align with healthcare M&A demand for specialized expertise and delivery capabilities. Baird Capital acquisitions in healthcare services other typically target recurring client relationships and project-based revenue streams in the healthcare sector. The private equity acquisition is structured as a $450m continuation fund tied to Baird Capital’s 2020 investment, with the closed status indicating finalization of fund terms for the Blue Matter Consulting acquisition.
Mobia Medical
May 8, 2026
Stryker→Amplitude Vascular Systems
May 8, 2026
Odyssey Therapeutics
May 8, 2026
Odyssey Therapeutics
May 8, 2026
Angelini Pharma→Catalyst Pharmaceuticals
May 7, 2026